三力制药 (603439.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

39.6x

Market Cap

CNY 4.89B

MomentumView details →

1D Return

−2.34%

YTD Return

+4.53%

RSI (14)

51.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

39.6x

Market Cap

CNY 4.89B

RSI (14)

51.6

MomentumView details →

1D Return

−2.34%

YTD Return

+4.53%

ProfitabilityView details →

Gross Margin

71.42%

Net Margin

2.91%

EBITDA Margin

8.22%

ROE (TTM)

3.26%

ROA (TTM)

1.73%

Asset Turnover

0.59x

GrowthView details →

Revenue YoY

−21.35%

EPS YoY

−80.85%

FCF YoY

+269.53%

Revenue CAGR 3Y

+12.33%

EPS CAGR 3Y

−39.22%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.43x

Current Ratio

1.57x

Quick Ratio

1.35x

Div Yield

0.49%

Div Rate

CNY 0.06

Div Growth 1Y

−82.35%

Financials snapshotView financials →

Revenue (TTM)

1.68B

Net Income (TTM)

48.72M

Op. CF (TTM)

193.25M

Latest newsMore news →

Sanli Pharmaceutical established a wholly-owned subsidiary, Shaanxi Sanli Pharmaceutical Drug Sales Co., Ltd., in Shaanxi Province, China, to engage in drug sales and related services.10d ago

Similar companies

ACADIA Pharmaceuticals Inc.ACAD Jacobio Pharmaceuticals Group Co., Ltd.01167.HK 康辰药业603590.SH 科兴制药688136.SH Celcuity Inc.CELC Edgewise Therapeutics, Inc.EWTX Find similar companies →

Latest newsMore news →

Sanli Pharmaceutical established a wholly-owned subsidiary, Shaanxi Sanli Pharmaceutical Drug Sales Co., Ltd., in Shaanxi Province, China, to engage in drug sales and related services.10d ago